Pfizer Says COVID-19 Vaccine Protection Lasts At Least Six Months, Protects Against Variants
The ongoing Phase 3 clinical trial of Pfizer/BioNTech's coronavirus vaccine confirms its protection lasts at least six months after the second dose, the companies said Thursday.